Print

Endologix Inc. Reports 33% Revenue Growth for the Second Quarter 2012  
7/27/2012 9:30:45 AM

IRVINE, Calif., July 26, 2012 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three and six months ended June 30, 2012.
//-->